Literature DB >> 16289986

Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics.

Clement Mugabe1, Ali O Azghani, Abdelwahab Omri.   

Abstract

Enhanced activity of liposomes-encapsulated antibiotics against clinical isolates of Pseudomonas aeruginosa has been documented with liposomes of low encapsulation efficiency. We sought to construct liposomes with high yield entrapment of aminoglycoside and macrolide antibiotics as well as favorable stability in storage and physiological conditions. Liposome-entrapped aminoglycosides (amikacin, gentamicin, tobramycin) and a macrolide (erythromycin) were prepared by a modified dehydration-rehydration vesicles (DRVs) method, and their particle size and entrapment efficiency were determined. We studied in vitro stability of these vesicles over a 48 h period at 4 and 37 degrees C in phosphate-buffered saline (PBS) and in plasma at 37 degrees C. The mean particle size of DRVs loaded with antibiotics varied from 163.37+/-38.44 to 259.83+/-11.80 nm with no significant difference in regard with the type of the antibiotics encapsulated. Encapsulation efficiency of DRVs loaded with amikacin, gentamicin, tobramycin, and erythromycin were 29.27+/-1.17, 33+/-0.76, 22.33+/-1.48 and 32.06+/-0.82% of initial amount of the drug, respectively. These vesicles were stable regardless of the experimental temperature. Indeed, the liposomes retained more than 75% of the initially encapsulated drugs for the study period of 48 h. DRVs incubated in plasma however, released more antibiotics than those incubated in PBS. In conclusion, using this modified DRV method, we obtained small sized vesicles with high yield entrapment for aminoglycoside and macrolide antibiotics. The technique may be utilized to overcome the low encapsulation efficiency associated with aminoglycoside and macrolide antibiotics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289986     DOI: 10.1016/j.ijpharm.2005.10.005

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

1.  Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.

Authors:  Clement Mugabe; Majed Halwani; Ali O Azghani; Robert M Lafrenie; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.

Authors:  Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

3.  Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors.

Authors:  Mai Alhajlan; Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

4.  Development of Biodegradable/Biocompatible Nanoliposome-Encapsulated Antimicrobial Essential Oils for Topical Creams and Gels.

Authors:  Israa Al-Ogaidi; Zoraida P Aguilar; Jackson O Lay
Journal:  ACS Omega       Date:  2022-06-27

5.  Characterization of zwitterionic phosphatidylcholine-based bilayer vesicles as efficient self-assembled virus-like gene carriers.

Authors:  Reihaneh Ramezani; Majid Sadeghizadeh; Mehrdad Behmanesh; Saman Hosseinkhani
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

6.  Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles.

Authors:  Bin Wang; Ling Tan; Dengpu Deng; Ting Lu; Changwei Zhou; Zhongkui Li; Zhenjie Tang; Zhongshi Wu; Hao Tang
Journal:  Int J Nanomedicine       Date:  2015-05-08

7.  Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis.

Authors:  Misagh Alipour; Zacharias E Suntres; Majed Halwani; Ali O Azghani; Abdelwahab Omri
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

8.  A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy.

Authors:  Behzad Baradaran; Ali Mohammadi; Sara Shamekhi; Nikoo Majidazar; Azita Dilmaghani; Saiedeh Razi Soofiyani; Nigel Aj McMillan; Farzaneh Lotfipour; Somayeh Hallaj-Nezhadi
Journal:  Drug Deliv Transl Res       Date:  2021-07-28       Impact factor: 4.617

9.  Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms.

Authors:  Anne-Sophie Messiaen; Katrien Forier; Hans Nelis; Kevin Braeckmans; Tom Coenye
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

10.  Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities.

Authors:  Moayad Alhariri; Majed A Majrashi; Ali H Bahkali; Faisal S Almajed; Ali O Azghani; Mohammad A Khiyami; Essam J Alyamani; Sameera M Aljohani; Majed A Halwani
Journal:  Int J Nanomedicine       Date:  2017-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.